Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin crossover study in fibromyalgia with comorbid depression on stable SSRI/SNRI therapy
2011-002480-19Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in fibromyalgia (FM) (2 arms), sponsored by Pfizer. Primary endpoint: Mean pain score. Started Nov 2011; status: completed.
02
Drugs
pregabalin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2011-002480-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002480-19.